학술논문

ICOSAPENT ETHYL IN ADDITION TO STATINS IS A COST-EFFECTIVE TREATMENT IN PATIENTS AT HIGH CARDIOVASCULAR RISK WITH ELEVATED TRIGLYCERIDES AND ESTABLISHED CARDIOVASCULAR DISEASE OR DIABETES WITH RISK FACTOR IN THE NETHERLANDS
Document Type
Journal
Source
VALUE IN HEALTH; DEC 2022, 25 12, pS308-pS308, 1p. Supplement: S
Subject
Language
English
ISSN
15244733